Citius Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Citius Pharmaceuticals

12/05/2022 23:44

* Citius Pharmaceuticals Inc  CTXR.OQ  reported a quarterly
adjusted loss of 5 cents​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of 7 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Citius Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 5 cents​.
    * The mean earnings estimate of analysts had fallen by
about 16.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Citius Pharmaceuticals Inc shares had fallen by 50.7% this
quarter and lost 42.7% so far this year.
    * The company reported a quarterly loss of $7.56 million.
    * Wall Street's median 12-month price target for Citius
Pharmaceuticals Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 10:43 p.m.  ​All
figures in US dollars unless otherwise stated